Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lassen

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|June 7, 2002
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trialAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.
Current Opinion in Hematology|August 13, 2003
Fondaparinux, the first selective factor Xa inhibitorAlexander G G Turpie, Bengt I Eriksson, Michael R Lassen, et al.
Thrombosis Research|June 30, 2007
Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplastyLars C Borris, Morten Breindahl, Camilla Ryge, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgeryB I Eriksson, K A Bauer, M R Lassen, et al.
Chest|December 12, 2003
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studiesAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.
The Journal of the American Academy of Orthopaedic Surgeons|December 24, 2004
FondaparinuxAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.
Journal of Thrombosis and Haemostasis : JTH|August 6, 2008
Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding eventsL C Borris, M Breindahl, M R Lassen, et al.
Chest|August 11, 2004
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end pointsAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.
Journal of the Southern Orthopaedic Association|February 25, 2003
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgeryAlexander G G Turpie, Bengt I Eriksson, Michael R Lassen, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin)J Fareed, J M Walenga, D Hoppensteadt, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|June 7, 2002
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trialAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.
Current Opinion in Hematology|August 13, 2003
Fondaparinux, the first selective factor Xa inhibitorAlexander G G Turpie, Bengt I Eriksson, Michael R Lassen, et al.
Thrombosis Research|June 30, 2007
Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplastyLars C Borris, Morten Breindahl, Camilla Ryge, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgeryB I Eriksson, K A Bauer, M R Lassen, et al.
Chest|December 12, 2003
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studiesAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.
The Journal of the American Academy of Orthopaedic Surgeons|December 24, 2004
FondaparinuxAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.
Journal of Thrombosis and Haemostasis : JTH|August 6, 2008
Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding eventsL C Borris, M Breindahl, M R Lassen, et al.
Chest|August 11, 2004
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end pointsAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.
Journal of the Southern Orthopaedic Association|February 25, 2003
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgeryAlexander G G Turpie, Bengt I Eriksson, Michael R Lassen, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin)J Fareed, J M Walenga, D Hoppensteadt, et al.
Pageof 14